EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Short-term neonatal outcomes in women with gestational diabetes treated using metformin versus insulin: a systematic review and meta-analysis of randomized controlled trials

Bo Sheng, Juan Ni, Bin Lv, Guoguo Jiang, Xuemei Lin, Hao Li

Acta Diabetologica · 03.01.2023 · 60 (5) · 595-608

DOI: 10.1007/s00592-022-02016-5 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Acta Diabetologica, online erschienen am 03.01.2023. Verfasst von Bo Sheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, West China Second University Hospital, Sichuan University, Chengdu, 610041, Sichuan, China. Hauptthemen laut MEDLINE: Diabetes, Gestational, Metformin, Hypoglycemia. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To expand the evidence base for the clinical use of metformin, we conducted a meta-analysis of randomized controlled trials (RCTs) comparing the efficacy and safety of metformin versus insulin with respect to short-term neonatal outcomes.

Methods

A comprehensive search of electronic databases (PubMed, Embase, Cochrane Library, and Web of Science) was performed. Two reviewers extracted the data and calculated pooled estimates by use of a random-effects model. In total, 24 studies involving 4355 participants met the eligibility criteria and were included in the quantitative analyses.

Results

Unlike insulin, metformin lowered neonatal birth weights (mean difference − 122.76 g; 95% confidence interval [CI] − 178.31, − 67.21; p < 0.0001), the risk of macrosomia (risk ratio [RR] 0.68; 95% CI 0.54, 0.86; p = 0.001), the incidence of neonatal intensive care unit admission (RR 0.73; 95% CI 0.61, 0.88; p = 0.0009), and the incidence of neonatal hypoglycemia (RR 0.65; 95% CI 0.52, 0.81; p = 0.0001). Subgroup analysis based on the maximum daily oral dose of metformin indicated that metformin-induced neonatal birth weight loss was independent of the oral dose.

Conclusions

Our meta-analysis provides further evidence that metformin is a safe oral antihyperglycemic drug and has some benefits over insulin when used for the treatment of gestational diabetes, without an increased risk of short-term neonatal adverse outcomes. Metformin may be particularly useful in women with gestational diabetes at high risk for neonatal hypoglycemia, women who want to limit maternal and fetal weight gain, and women with an inability to afford or use insulin safely.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalMetforminHypoglycemiaPregnancyInfant, NewbornFemaleHumansInsulinHypoglycemic AgentsRandomized Controlled Trials as TopicBirth WeightWeight Gain

Stichwörter der Autor:innen

Gestational diabetes mellitusInsulinMetforminNeonatal outcomesRandomized controlled trials

Substanzen

MetforminInsulinHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Anesthesiology, West China Second University Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
  • Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Sichuan University, Chengdu, 610041, Sichuan, China.
  • Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
  • Department of Hospital Infection Management, The Second Hospital of Chengdu City, Chengdu, 610041, Sichuan, China.
  • Department of Anesthesiology, West China Second University Hospital, Sichuan University, Chengdu, 610041, Sichuan, China. xuemeilinscu@163.com.
  • Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Sichuan University, Chengdu, 610041, Sichuan, China. xuemeilinscu@163.com.

Zitieren

APA

Sheng, B., Ni, J., Lv, B., Jiang, G., Lin, X., & Li, H. (2023). Short-term neonatal outcomes in women with gestational diabetes treated using metformin versus insulin: a systematic review and meta-analysis of randomized controlled trials. Acta Diabetologica, 60(5), 595-608. https://doi.org/10.1007/s00592-022-02016-5

Vancouver

Sheng B, Ni J, Lv B, Jiang G, Lin X, Li H. Short-term neonatal outcomes in women with gestational diabetes treated using metformin versus insulin: a systematic review and meta-analysis of randomized controlled trials. Acta Diabetologica. 2023;60(5):595-608. doi:10.1007/s00592-022-02016-5

BibTeX
@article{Sheng2023,
  author = {Sheng, Bo and Ni, Juan and Lv, Bin and Jiang, Guoguo and Lin, Xuemei and Li, Hao},
  title = {Short-term neonatal outcomes in women with gestational diabetes treated using metformin versus insulin: a systematic review and meta-analysis of randomized controlled trials},
  journal = {Acta Diabetologica},
  year = {2023},
  volume = {60},
  number = {5},
  pages = {595--608},
  doi = {10.1007/s00592-022-02016-5}
}
Kostenlos starten →